March 2024 Newsletter
Welcome to the March Cresset newsletter where we share our latest results for GPCR benchmarks using Flare™ FEP, Cresset wins ...
News
In this case study, Giovanna Tedesco, used Activity Atlas to analyze the SAR of a large data set of Orexin-2 receptor ligands taken from the patent literature to rapidly investigate and understand the electrostatic, hydrophobic and shape features of each recently published scaffold.
We are released two new webclips on features of our software:
As graphics cards and CPUs have become faster since the release of BlazeGPU, Dr Mark Mackey looks at how the new hardware performs.
What type of tasks and projects do we work on? Dr Martin Slater explains.
Domainex and Cresset Announce Drug Discovery Services Alliance
This case study describes how Re-Pharm scientists used Forge, Cresset’s computational chemistry suite for understanding SAR and design, to find an active compound that Re-Pharm has patented as a novel anti-inflammatory agent with ‘steroid sparing’ capability.
Scientific program plus software tips and tricks.
Find out more and register free.
16 June: Scientific program featuring presentations on Cresset software and Discovery Services plus: Boehringer Ingelheim, Eli Lilly, GlaxoSmithKline, University of Hertfordshire, more to be confirmed.
17 June: Workshops and clinics.
Find out more. Registration will open in February.